Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “Given the important role that the 340B program plays in our communities, we strongly urge CMS to abandon this proposal and redirect its efforts toward actions to address the cost of drugs via other policies that would not harm our constituents,” the representatives wrote. CMS has proposed to pay for separately payable, non pass-through drugs purchased through the 340B program at the average sales price minus 22.5%, rather than the current rate of ASP plus 6%. Reps. David McKinley (R-WV), Mike Thompson (D-CA) and David Kustoff (R-TN) spearheaded the letter. “The AHA thanks Representatives McKinley, Thompson, and Kustoff for leading this bipartisan effort to protect patient care by urging CMS to rescind its misguided proposal to reduce Medicare Part B payments for 340B hospitals,” said AHA Executive Vice President Tom Nickels.

Related News Articles

Headline
The Centers for Medicare…
Headline
The Medicare Hospital Insurance Trust Fund will have sufficient funds to pay full benefits until 2026, according to the latest annual report from the Medicare…
Headline
The Centers for Medicare…
Headline
Critical Access Hospitals, certain clinics, and other eligible outpatient facilities that provide primary care or substance use disorder treatment to high-need…
Headline
The Health Resources and Services Administration will host a webinar for applying for grants to coordinate maternal and obstetrics care in rural regions.
Headline
"Medicare for All" sounds like a good idea ... but we have a better way to meet today’s challenges, create a healthier tomorrow – and advance health in America.